|
業務類別
|
Biotechnology |
|
業務概覽
|
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction,the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders. |
| 公司地址
| 20 Park Plaza, Suite 424, Boston, MA, USA, 02116 |
| 電話號碼
| +1 617 744-4400 |
| 傳真號碼
| +1 434 220-0722 |
| 公司網頁
| https://www.cervomed.com |
| 員工數量
| 15 |
| Dr. Mark De Rosch, PhD |
Executive Vice President, Regulatory and Government Affairs and Program Management |
-- |
13/03/2026 |
| Dr. Matthew Winton, PhD |
Chief Commercial and Chief Business Officer |
-- |
13/03/2026 |
| Mr. William R. Elder |
General Counsel and Chief Financial Officer |
美元 406.48K |
13/03/2026 |
| Ms. Kelly Blackburn, M.H.A |
Executive Vice President, Clinical Development |
-- |
13/03/2026 |
| Dr. Marco Verwijs, PhD |
Executive Vice President, Technical Operations |
-- |
13/03/2026 |
| Dr. John J. Alam, M.D. |
Chief Executive Officer, President and Director |
美元 538.54K |
13/03/2026 |
|
|
| Mr. David Quigley |
Director |
13/03/2026 |
| Dr. Joshua S. Boger,PhD |
Chairman of the Board |
13/03/2026 |
| Ms. Jane H. Hollingsworth, J.D. |
Independent Director |
13/03/2026 |
| Dr. Marwan Noel Sabbagh, M.D. |
Independent Director |
13/03/2026 |
| Mr. Frank Zavrl |
Independent Director |
13/03/2026 |
| Mr. Jeffrey V. Poulton |
Independent Director |
13/03/2026 |
| Dr. John J. Alam, M.D. |
Chief Executive Officer, President and Director |
13/03/2026 |
| Dr. Sylvie Gregoire,Pharm.D. |
Director |
13/03/2026 |
|
|
|
|
